Search
for
Sort by
Research 30 of 161
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Presentation and Management of Cutaneous Manifestations of COVID-19
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Cutaneous Reactions to Drugs
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Cutaneous drug reactions
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- COVID-19 infection leading to acute pustular dermatoses
- Dermatological Manifestations of COVID-19: A Brief Review
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Psychoactive drugs and skin
- Adverse Cutaneous Reactions to Antipsychotics
- Anticonvulsant-Induced Cutaneous Reactions
- Cutaneous Manifestations of COVID-19
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Cutaneous Manifestations of Lupus Erythematosus
- Drug-Induced Skin, Nail and Hair Disorders
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- Concurrence of Palmoplantar Psoriasiform Eruptions and Hair Loss during Carbamazepine Treatment
- The Impact of Covid-19 Pandemic on the Clinical Course of Pediatric Skin Disorders: A Cross-Sectional Study
- Drug eruptions in dermatology
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms